We're assuming that the physician is properly trained in the issues of a particular drug. The medical community who sat at the table with us has indicated that there isn't sufficient education, certainly around the issue.
Second, there's the fact that veterinarians receive far more training around pain management than physicians for humans do. It's not surprising; their patients don't talk back. But I'm not trying to be cheeky here. I'm simply stating that I think part of the problem that Mr. Marston asked about—how we got here—is that there was perhaps an assumption that there is a greater level of understanding and education than is currently being provided. The medical community has said that to us clearly, and has indicated they wish to see additional prescriber education, not only in terms of curriculum when you're going through medical school but also post-graduation. In that regard, a number of post-graduate education programs are largely funded by pharmaceutical industries. There was attention to that matter brought at the discussion as well, to ensure that there is a sufficient distance from any potential conflict of interest in education. Finally, the role of the colleges of physicians is essential to ensuring the uptake of appropriate clinical practice. That is a check and balance that physicians themselves indicate is absolutely critical to knowing if they're prescribing rightly or wrongly. It's our only early warning system, if you wish, and it's one that's managed by their own practice as professionals.
I'd urge you to save or repeat that question for Dr. Susan Ulan, who will be here with the College of Physicians and Surgeons of Alberta. That's precisely their role. You will probably get a better and shorter answer from her.